Efficacy and safety of the use of omalizumab in a patient with difficult-to-control severe asthma and antiphospholipid antibody syndrome
Crossref DOI link: https://doi.org/10.1186/1939-4551-8-S1-A219
Published Print: 2015
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Villela, Rosangela
Melo, Janaina M
Nociti, Thais
Araujo, Ana Carla S
Arruda, L Karla
Text and Data Mining valid from 2015-01-01
Version of Record valid from 2019-07-26
License valid from 2015-01-01